Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED50 of intrathecal hyperbaric prilocaine for ambulatory fusion-targeted prostate biopsy
2022-002179-12Phase 4Active
- Sponsor
- Matilde Zaballos
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prilocaine in prostate biopsy pain and procedural discomfort, sponsored by Matilde Zaballos. Primary endpoint: Sensory block adequacy (primary). Started Jul 2022; status: active.
02
Drugs
prilocaine
03
Conditions
prostate biopsy painprocedural discomfort
Beyond the preview
Go deeper on 2022-002179-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002179-12.